Veru V2011801

To assess the safety and tolerability of sabizabulin monotherapy, and Trodelvy/sabizabulin combination therapy

Trial overview

Topic

Veru V2011801

Description

Phase 2 Clinical Efficacy and Safety Study of Sabizabulin (VERU-111) Monotherapy and Sacituzumab Govitecan-hziy/Sabizabulin Combination Therapy for the Treatment of Metastatic Triple Negative Breast Cancer

Contact

Florida East Coast - Aventura

Peggy Mouradian & Nancy Joseph